Locations:
Search IconSearch

Trigeminal Neuralgia: A Primer on Diagnosis and Treatment (Podcast)

Pharmacologic, procedural and surgical treatments abound

Trigeminal neuralgia, or tic douloureux, can cause sudden, sporadic and debilitating burning or shock-like pain in the face or head. While rare — affecting only four to five out of 100,000 people — it affects more women than men and is more common in older adults. Patients of any age require a thorough workup since trigeminal neuralgia can be triggered by multiple sclerosis or a brain tumor.

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

Emad Estemalik, MD, Section Head of Headache and Facial Pain in Cleveland Clinic’s Center for Neurological Restoration, discusses the challenges of diagnosing and treating this condition in the latest episode of Cleveland Clinic’s Neuro Pathways podcast.

His brief audio interview highlights the following:

  • How to make a correct diagnosis — including the main differential
  • The importance of multidisciplinary care in determining treatment
  • Options for surgical treatment and when to consider them

Click the player below to listen to the podcast now, or read on for a short edited excerpt. Check out more Neuro Pathways episodes at clevelandclinic.org/neuropodcast or wherever you get your podcasts.

Excerpt from the podcast

Dr. Estemalik: We always like to have patients first seen by one of our headache specialists or neurologists to ensure the accurate diagnosis has been made and the workup has been concluded. Patients should exhaust all pharmacological and procedural treatments before seeing a neurosurgeon. At a later point when, for instance, treatments are not working anymore, we discuss surgical approach.

The vast majority of patients do respond to the initial treatment, so that is good news. Some of the drugs that we use — like seizure medications, antidepressants and skeletal muscle relaxants — though they work, often have side effects. We try to work with the patient on the best medical option.

Then there are certain procedures that are very simple — like trigeminal nerve blocks and botulinum toxin injections — that also can provide pain relief. Our goal is to exhaust all these options before going to the next step, surgical intervention.

Advertisement

Again, we have a group of physicians, neurologists, headache specialists and surgeons who work closely together in setting the treatment plan.

The one thing we always tell our trigeminal neuralgia patients is that this is a chronic illness. We are not going to cure it right away, and it’s very, very likely that it’s always going to be there.

Advertisement

Related Articles

16-NEU-2800-Kubu-101058161-650×450
What Do Patients Want from DBS for Parkinson’s Disease?

New study advances understanding of patient-defined goals

photo of a man sleeping at a desk, with a podcast icon overlay
March 15, 2024/Neurosciences/Podcast
Diagnosis and Management of Idiopathic Hypersomnia (Podcast)

Testing options and therapies are expanding for this poorly understood sleep disorder

illustration of an alzheimer brain and a packet of sildenafil pills
March 11, 2024/Neurosciences/Research
Sildenafil as an Alzheimer’s Candidate Drug: Further Support From Insurance Database and Mechanistic Studies

Real-world claims data and tissue culture studies set the stage for randomized clinical testing

brain scan showing perimesencephalic subarachnoid hemorrhage
Study Supports Less-Strict Monitoring for Nonaneurysmal Perimesencephalic SAH Without Hydrocephalus

Digital subtraction angiography remains central to assessment of ‘benign’ PMSAH

illustrated brain with the letters "AI" on a computer circuit board
As AI Tools Emerge, Be Proactive and Engaged to Shape Their Development

Cleveland Clinic neuromuscular specialist shares insights on AI in his field and beyond

histology image of a gray matter lesion in a multiple sclerosis brain
Study Suggests Protective Role for Microglia at Borders of Gray Matter Lesions in Progressive MS

Findings challenge dogma that microglia are exclusively destructive regardless of location in brain

series of digital-looking brain icons with a podcast button overlay on top
March 1, 2024/Neurosciences/Podcast
Harnessing the Power of AI in Medicine (Podcast)

Neurology is especially well positioned for opportunities to enhance clinical care and medical training

illustration of a neuron affected by multiple sclerosis
Clinical Trials in Progressive MS: An Assessment of Advances and Remaining Challenges

New review distills insights from studies over the past decade

Ad